Update your tester profile Login
  • Study 1408: Healthy Male and Female Participants

    Research Purpose: Study 1408 is designed to evaluate an investigational drug being developed for the treatment of certain types of inflammatory disorders. Different dosing levels of the investigational drug will be compared to a placebo.  The following will be evaluated:

    • How much of the investigational drug gets into the blood
    • How quickly the body process and eliminates the investigational drug
    • The safety/tolerability of the investigational drug

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women are allowed to participate.   

    Age

    18-55 years

    Body Mass Index (BMI)

    18 and 32 kg/m²

    Tobacco/Nicotine Use

    No more than the equivalent of 5 cigarettes/week within 2 months before screening.  No tobacco or nicotine use the week before screening or any time during study participation.

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year of the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, or vitamins that are not listed below

    Allowed Medications

    Limited prescription hormonal birth control use is permitted:  Birth control patches and the vaginal ring are allowed.  All other forms of hormonal birth control used in the 30 days prior to dose of the study drug are exclusionary

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 10 weeks. 

    Inpatient Stays

    • Participants will stay at Prism Clinical Research 3 times. 
    • Inpatient stays will last approximately 72 hours (three overnights)
    • Each inpatient stay will be separated by 3 weeks

    Outpatient Visits

    • There are at total of 16 outpatient visits
    • 5 outpatient visits will take place after each of the first two inpatient stays.  6 outpatient visits will take place after the 3 inpatient stay

     

    Compensation: Up to $3,500.00

  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • Study 1400: Healthy, Sexually Active Male and Female Participants

    Research Purpose:  Study 1400

    The effect of the study drug on sexual functioning (i.e. frequency of sexual activity, thoughts, arousal, physical response etc.) when given to healthy sexually active adults.

    • The effect of the study drug compared to the effect of placebo and paroxetine (an FDA approved comparator drug) on sexual functioning

     

    Screening Qualifications: Participants must meet the following minimum criteria in order to qualify for a screening appointment:

    • Males and Females allowed. Age 18-45 years
    • Body Mass Index (BMI) between 18 and 35
    • No tobacco or nicotine use in the previous 12 months
    • Must be healthy; not being evaluated or treated for any medical conditions
    • Must not require regular use of prescription medications, non-prescription medications, or vitamins
    • Must test negative for drugs of abuse.  Must have no history of drug or alcohol abuse within the previous 5 years.
    • Must be sexually active:  engaging in sexual activity at least 2 times per week on average over the past 3 months.
    • Cannot have a diagnosis of disorders related to sexual functioning including but not limited to erectile dysfunction, premature ejaculation, or any surgeries or medical procedures on genital/reproductive organs
    • Must be able and willing to discuss sexual activity/functioning with Prism staff and fill out questionnaires related to sexual activity/functioning
    • Must be able and willing to take daily, at-home dosing of the study drug

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 6 weeks.  During that time, participants will visit Prism Clinical Research for approximately 7 outpatient appointments.  Participants will also take daily, at-home doses of the study drug and will keep an outpatient study diary.

     

    Compensation: Up to $1575.00 for study participation time.

Recruitment and Volunteer Demographics

Prism Clinical Research recognizes the need to continually grow our diverse volunteer database populations. Through a multi-faceted enrollment process that includes a dedicated recruitment department, collaborative physician partnerships, advertising and subject referral programs, Prism Clinical Research can deliver Phase I-II results in the following populations:

  • HIV

  • Hepatic

  • Renal (Pre-ESRD, ESRD)

  • Type 2 Diabetes

  • Obesity

  • Healthy Male/Female/Elderly

  • Gilbert’s subset

  • Rheumatoid Arthritis

  • Epilepsy

  • Multiple Sclerosis
  • GI (IBS & Crohn’s)

  • Celiac
  • COPD, Allergy and Asthma

  • High Cholesterol

  • Hypertensive

  • Alzheimer's Disease
  • Ophthalmology

  • Slow Metabolizers

  • Osteoporosis
  • Osteoarthritis
  • Lupus

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel